Isolation of a TRAIL Antagonist from the Serum of HIV-infected Patients

Autor: Schnepple, David J., Shepard, Brett, Bren, Gary D., Cummins, Nathan W., Natesampillai, Sekar, Trushin, Sergey, Algeciras-Schimnich, Alicia, Meng, Xue W., Sainski, Amy M. ^**, Rizza, Stacey A., Kaufmann, Scott H. ^**, Badley, Andrew D.

Publikováno v: In Journal of Biological Chemistry 14 October 2011 286(41):35742-35754

Short Communication: CD4 T Cell Declines Occurring During Suppressive Antiretroviral Therapy Reflect Continued Production of Casp8p41

Autor: Cummins, Nathan W. Neuhaus, Jacqueline Sainski, Amy M. and Strausbauch, Michael A. Wettstein, Peter J. Lewin, Sharon R. and Plana, Montserrat Rizza, Stacey A. Temesgen, Zelalem and Touloumi, Giota Freiberg, Matthew Neaton, James Badley, Andrew D. INSIGHT SMART Study Grp

Most patients on suppressive antiretroviral therapy (ART) experience improvements in CD4 T cell count. However, some patients with undetectable viral load continue to lose CD4 T cells for unknown reasons. Casp8p41 is a host-derived protein fragment t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::45c48f30a743564ae8990aca4a33502c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3161651

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells.

Autor: Cummins NW; Division of Infectious Diseases, Mayo Clinic Rochester, Rochester, MN USA., Sainski AM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester, Rochester, MN USA., Natesampillai S; Division of Infectious Diseases, Mayo Clinic Rochester, Rochester, MN USA., Bren GD; Division of Infectious Diseases, Mayo Clinic Rochester, Rochester, MN USA., Badley AD; Division of Infectious Diseases, Mayo Clinic Rochester, Rochester, MN USA.

Publikováno v: Molecular and cellular therapies [Mol Cell Ther] 2014 Jan 03; Vol. 2, pp. 1. Date of Electronic Publication: 2014 Jan 03 (Print Publication: 2014).